Generated by AI
InMode Ltd. is a medical technology company that develops, manufactures, and markets minimally invasive and non-invasive aesthetic treatment systems. Its current product portfolio is built around radio frequency-based platforms used in body and face contouring, skin tightening, fat reduction, skin rejuvenation, and women’s health procedures. The company also offers solutions for dermatology, plastic surgery, gynecology, otolaryngology, and ophthalmology, reflecting a broad focus across medical aesthetics and specialty care. InMode serves hospitals, clinics, and medical practices through a global distribution network, with commercial activity across the United States, Europe, Asia, and other international markets. Headquartered in Yokneam, Israel, InMode Ltd. is recognized for energy-based devices that support office-based procedures and expand treatment options in the growing aesthetic medicine market.
WebsiteTavor Building
Yokne'am, 2069206
Israel
The latest articles about INMD.
InMode is rated a Hold after Q3 revenue fell 1.2% year over year; growth or margin leverage is needed for a bullish stance. Read here for more on INMD stock.
Summary of Jul 9's posts. Generated by AI.
Summary of Jun 24's posts. Generated by AI.
Summary of Feb 15's posts. Generated by AI.
Summary of Jan 28's posts. Generated by AI.
Investors talking about INMD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.